✦ LIBER ✦

O-4 A randomized phase II study of docetaxel versus docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first line chemotherapy

✍ Scribed by Groen, H.J.M.; Wachters, F.M.; Biesma, B.; Schramel, F.M.N.H.; Stigt, J.A.; Smit, E.F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised phase II trial of docetaxel

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Irinotecan and docetaxel as first line c

✍ Raez, Luis E; Rosado, Manuel F; Santos, Edgardo S; Reis, Isildinha M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase II randomized study of weekly doce

✍ Chou, Kun-ta; Chen, Yuh-Min; Shih, Jen-Fu; Perng, Reury-Perng; Tsai, Chun-Ming; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 122 KB

A phase I/II trial of weekly docetaxel a

✍ Stinchcombe, Thomas E.; Bůžková, Petra; Choksi, Janak; Taylor, Mark; Bakri, Kama 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Phase I/II Trial of Docetaxel and Carbop

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB